证券代码：836957 证券简称：汉维科技 公告编号：2023-048 东莞市汉维科技股份有限公司 第三届董事会第十六次会议决议公告 本公司及董事会全体成员保证公告内容的真实、准确和完整，没有虚假记载、 误导性陈述或者重大遗漏，并对其内容的真实性、准确性和完整性承担个别及连 带法律责任。 一、会议召开和出席情况 （一）会议召开情况 1.会议召开时间：2023 年 4 月 26 日 2.会议召开地点：东莞市汉维科技股份有限公司会议室 3.会议召开方式：现场及视频方式 4.发出董事会会议通知的时间和方式：2023 年 4 月 15 日以书面或电子方式 发出 5.会议主持人：周述辉先生 6.会议列席人员：监事及高级管理人员 7.召开情况合法、合规、合章程性说明： 本次会议从会议召集、召开、议案审议程序等方面符合《公司法》等法律、 法规、规范性文件以及《公司章程》的规定。 （二）会议出席情况 二、议案审议情况 （一）审议通过《东莞市汉维科技股份有限公司 2023 年一季度报告》 1.议案内容： 根据《中华人民共和国公司法》及《东莞市汉维科技股份有限公司章程》、 等相关规定，公司将在北京证券交易所信息披露平台披露公司 ...

证券代码：836957 证券简称：汉维科技 公告编号：2023-051 东莞市汉维科技股份有限公司 （一）会议召开情况 1.会议召开时间：2023 年 4 月 26 日 2.会议召开地点：东莞市汉维科技股份有限公司会议室 3.会议召开方式：现场及网络投票方式 2022 年年度股东大会决议公告 本公司及董事会全体成员保证公告内容的真实、准确和完整，没有虚假记载、 误导性陈述或者重大遗漏，并对其内容的真实性、准确性和完整性承担个别及连 带法律责任。 一、会议召开和出席情况 4.会议召集人：东莞市汉维科技股份有限公司董事会 5.会议主持人：周述辉先生 6.召开情况合法、合规、合章程性说明： 本次股东大会的召集及召开时间、方式、召集人及主持人符合《中华人民共 和国公司法》、《东莞市汉维科技股份有限公司章程》及《股东大会议事规则》等 有关规定。 （二）会议出席情况 出席和授权出席本次股东大会的股东共 5 人，持有表决权的股份总数 80,476,000 股，占公司有表决权股份总数的 75%。 其中通过网络投票参与本次股东大会的股东共 0 人，持有表决权的股份总数 0 股，占公司有表决权股份总数的 0%。 （三）公司董事、 ...

北京德恒（深圳）律师事务所 关于东莞市汉维科技股份有限公司 2022 年年度股东大会的 法律意见 深圳市福田区金田路 4018 号安联大厦 B 座 11 楼 电话:0755-88286488 传真:0755-88286499 邮编:518026 北京德恒（深圳）律师事务所 关于东莞市汉维科技股份有限公司 2022 年年度股东大会的法律意见 北京德恒（深圳）律师事务所 法律意见 德恒 06G20220444-00003 号 致：东莞市汉维科技股份有限公司 东莞市汉维科技股份有限公司（以下简称"公司"）2022 年年度股东大会 （以下简称"本次会议"）于 2023 年 4 月 26 日（星期三）召开。北京德恒（深 圳）律师事务所（以下简称"德恒"）受公司委托，指派郑婕律师、郑珠玲律师 （以下简称"德恒律师"）出席了本次会议。根据《中华人民共和国证券法》（以 下简称"《证券法》"）《中华人民共和国公司法》（以下简称"《公司法》"） 《东莞市汉维科技股份有限公司章程》（以下简称"《公司章程》"）《东莞市 汉维科技股份有限公司股东大会议事规则》（以下简称"《股东大会议事规则》"） 的规定，德恒律师就本次会议的召集、召开 ...

Financial Performance - Operating revenue for Q1 2023 was CNY 95,926,709.73, down 21.81% year-over-year from CNY 122,686,036.38[10] - Net profit attributable to shareholders for Q1 2023 was CNY 4,928,870.08, a decline of 54.12% compared to CNY 10,742,708.31 in the same period last year[10] - Basic earnings per share decreased by 58.33% to CNY 0.05 from CNY 0.12[11] - Total operating costs for Q1 2023 were ¥92,089,131.20, down 17.1% from ¥110,989,232.01 in Q1 2022[38] - Net profit for Q1 2023 was ¥4,387,054.94, representing a decline of 58.9% from ¥10,687,963.17 in Q1 2022[39] - Basic and diluted earnings per share were both 0.06 yuan, compared to 0.11 yuan in the same period last year, representing a decrease of 45.45%[43] Cash Flow - The company's cash flow from operating activities fell by 70.24% to CNY 3,963,672.86, primarily due to reduced cash inflow from operations[12] - Net cash flow from operating activities was 3,963,672.86 yuan, a significant decline of 70.24% from 13,317,782.90 yuan in the previous year[46] - Cash inflow from operating activities totaled 83,428,130.97 yuan, down 34.06% from 126,531,404.21 yuan year-over-year[44] - Cash outflow from operating activities was 79,464,458.11 yuan, a decrease of 29.78% compared to 113,213,621.31 yuan in the same period last year[44] - Net cash flow from investment activities was -92,660,223.62 yuan, compared to a positive cash flow of 8,438,239.56 yuan in the previous year[46] - Cash inflow from investment activities was 30,160,270.77 yuan, down 74.60% from 118,591,931.41 yuan year-over-year[46] - Cash outflow from investment activities increased to 122,820,494.39 yuan, up 11.54% from 110,153,691.85 yuan in the previous year[46] - The ending cash and cash equivalents balance was 105,433,393.29 yuan, compared to 78,923,703.50 yuan at the end of the same period last year, reflecting an increase of 33.67%[46] - The company reported a net decrease in cash and cash equivalents of -89,245,378.30 yuan, contrasting with an increase of 22,424,006.67 yuan in the previous year[46] Assets and Liabilities - Total assets as of March 31, 2023, were CNY 580,332,764.51, a decrease of 0.72% compared to the end of 2022[10] - Total current assets decreased to CNY 400,795,848.41 from CNY 420,010,956.61, a decline of approximately 4.3%[29] - Cash and cash equivalents decreased to CNY 122,755,818.65 from CNY 220,156,949.93, a drop of about 44.3%[29] - Total non-current assets increased to CNY 179,536,916.10 from CNY 164,559,019.68, an increase of approximately 9.1%[30] - Total liabilities decreased to CNY 173,716,977.62 from CNY 181,612,127.38, a reduction of about 4.8%[31] - Total equity attributable to shareholders increased to CNY 401,181,783.94 from CNY 396,982,030.82, an increase of approximately 1.1%[31] - Total liabilities decreased to ¥137,373,855.33 in Q1 2023 from ¥145,947,416.84 in Q1 2022, a reduction of 5.9%[35] - Total equity increased to ¥404,988,228.44 in Q1 2023 from ¥398,954,602.18 in Q1 2022, an increase of 1.5%[35] Shareholder Information - The company reported a total of 92,047,198 shares held by the top ten shareholders, representing 85.78% of total shares[19] - The largest shareholder, Zhou Shuhui, holds 34,676,200 shares, accounting for 32.32% of total shares[19] Expenses - Management expenses increased by 38.44%, mainly due to the commencement of depreciation for the Indonesian facility starting January 2023[12] - Financial expenses rose by CNY 1,320,500, primarily due to increased interest expenses from land leasing and loans in Indonesia[12] - Research and development expenses for Q1 2023 were ¥3,733,679.30, slightly down from ¥3,868,272.49 in Q1 2022[38] - Financial expenses for Q1 2023 were ¥1,128,468.83, compared to a financial income of ¥192,079.74 in Q1 2022[38] Other Information - There are no ongoing litigation or arbitration matters reported during the period[22] - The company has not engaged in any external guarantees or loans during the reporting period[22] - The company has disclosed that there are no significant changes in previously reported commitments[24] - The company has a bank credit limit of up to 100 million RMB approved by the board of directors[23] - The company has pledged assets totaling 59,324,072.68 RMB, which constitutes 10.21% of total assets[25] - The company has a total of 17,322,425.36 RMB in cash pledged as collateral, representing 2.98% of total assets[25] - The company’s fixed assets, including real estate, are valued at 10,944,045.32 RMB and are mortgaged for bank credit[25] - The company executed daily related transactions in compliance with internal procedures[22] - The company reported a credit impairment loss of ¥929,659.95 in Q1 2023, compared to a gain of ¥33,450.85 in Q1 2022[38] - Total comprehensive income for the period was 6,033,626.26 yuan, down from 10,485,786.80 yuan year-over-year[43] - The company is focusing on expanding its trading financial assets, which saw a significant increase, indicating a strategic shift towards investment opportunities[29]

证券代码：836957 证券简称：汉维科技 公告编号：2023-047 东莞市汉维科技股份有限公司 2022 年年度报告业绩说明会预告公告 本公司及董事会全体成员保证公告内容的真实、准确和完整，没有虚假记 载、误导性陈述或者重大遗漏，并对其内容的真实性、准确性和完整性承担个 别及连带法律责任。 一、 说明会类型 东莞市汉维科技股份有限公司（以下简称"公司"）于 2023 年 3 月 29 日在 北京证券交易所信息披露平台（www.bse.cn）披露了《2022 年年度报告》（公告 编号：2023-027）及《2022 年年度报告摘要》（公告编号：2023-032），为方便广 大投资者更深入了解公司 2022 年年度经营业绩的具体情况，加强与投资者的互 动交流，公司拟召开 2022 年年度报告业绩说明会。 二、 说明会召开的时间、地点 （一）会议召开时间：2023年4月14日（星期五）15:00-17:00 。 （二）会议召开地点 本次年度报告业绩说明会将采用网络方式召开，投资者可登陆全景网"投 资者关系互动平台"（http://ir.p5w.net）参与本次业绩说明会。 三、 参加人员 公司董事长、总经理：周 ...

证券代码：836957 证券简称：汉维科技 公告编号：2023-047 东莞市汉维科技股份有限公司 2022 年年度报告业绩说明会预告公告 本公司及董事会全体成员保证公告内容的真实、准确和完整，没有虚假记 载、误导性陈述或者重大遗漏，并对其内容的真实性、准确性和完整性承担个 别及连带法律责任。 东莞市汉维科技股份有限公司（以下简称"公司"）于 2023 年 3 月 29 日在 北京证券交易所信息披露平台（www.bse.cn）披露了《2022 年年度报告》（公告 编号：2023-027）及《2022 年年度报告摘要》（公告编号：2023-032），为方便广 大投资者更深入了解公司 2022 年年度经营业绩的具体情况，加强与投资者的互 动交流，公司拟召开 2022 年年度报告业绩说明会。 二、 说明会召开的时间、地点 （一）会议召开时间：2023年4月14日（星期五）15:00-17:00 。 （二）会议召开地点 本次年度报告业绩说明会将采用网络方式召开，投资者可登陆全景网"投 资者关系互动平台"（http://ir.p5w.net）参与本次业绩说明会。 一、 说明会类型 三、 参加人员 公司董事长、总经理：周 ...

一、《关于公司 2022 年年度报告及其摘要的议案》的事先认可意见及独立 意见 经审阅《东莞市汉维科技股份有限公司 2022 年年度报告》及其摘要，我们 认为：公司编制的《东莞市汉维科技股份有限公司 2022 年年度报告》及其摘要， 对截至 2022 年 12 月 31 日的经营成果及财务状况，真实、客观、完整地反映了 公司的经营情况，公司 2022 年年度报告及报告摘要的编制和审议程序符合法律、 法规、公司章程和公司内部管理制度的各项规定。不存在重大遗漏和误导性陈述， 且不存在损害公司股东利益的情形。 我们一致同意《关于公司 2022 年年度报告及其摘要的议案》，同意将上述议 案提交公司年度股东大会审议。 二、《关于公司 2022 年度利润分配预案的议案》的事先认可意见及独立意见 证券代码：836957 证券简称：汉维科技 公告编号：2023-034 东莞市汉维科技股份有限公司 独立董事关于第三届董事会第十五次会议相关议案的事先认可意见 及独立意见公告 本公司及董事会全体成员保证公告内容的真实、准确和完整，没有虚假记 载、误导性陈述或者重大遗漏，并对其内容的真实性、准确性和完整性承担个 别及连带法律责任。 ...

Financial Performance - The company's operating revenue for 2022 was CNY 487.88 million, a decrease of 7.20% compared to CNY 525.74 million in 2021[29]. - The net profit attributable to shareholders for 2022 was CNY 35.87 million, an increase of 8.87% from CNY 32.94 million in 2021[29]. - The total assets increased by 17.16% to CNY 584.57 million in 2022, up from CNY 498.96 million in 2021[31]. - The total liabilities decreased by 17.03% to CNY 181.61 million in 2022, down from CNY 218.88 million in 2021[31]. - The company's gross profit margin improved to 14.65% in 2022, compared to 13.47% in 2021[29]. - The cash flow from operating activities for 2022 was CNY 63.80 million, a significant increase of 552.21% from a negative CNY 14.11 million in 2021[33]. - The weighted average return on equity based on net profit attributable to shareholders was 12.30% in 2022, down from 12.81% in 2021[29]. - The company reported a basic earnings per share of CNY 0.39 in 2022, an increase of 8.33% from CNY 0.36 in 2021[29]. - The company experienced a net profit growth rate of 7.82% in 2022, compared to a decline of 23.61% in 2021[34]. - The company achieved a total non-recurring profit and loss of 3,346,079.41 in 2022, compared to 4,085,289.64 in 2021, indicating a decline of approximately 18.1%[40]. Production and Capacity Expansion - The company plans to add 60,000 tons of fatty acid salt additives, 25,000 tons of fatty acid esters, 25,000 tons of fatty acid amides, and 10,000 tons of special additives upon completion of its fundraising projects[13]. - The company commenced construction of its environmental additives production project on March 5, 2022[4]. - The company has completed the construction of its environmental additive production project, which began on March 5, 2022[49]. - The company expects continued growth in the PE wood-plastic production capacity, with an annual compound growth rate of 10%-20% projected until 2025[57]. - The company will prioritize market expansion efforts to ensure the timely absorption of new production capacity from fundraising projects[128]. Research and Development - The company holds a total of 30 patents, including 10 invention patents, an increase from 29 patents in the previous period[93]. - The company is in the trial production stage for several R&D projects, including a low-foam grinding aid for UV wood coatings, which aims to address existing processing issues[94]. - A new water-based zinc stearate emulsion is being developed, expected to enhance product performance and support industry upgrades[95]. - The company is working on a low-acid magnesium stearate project aimed at improving competitiveness in the pharmaceutical-grade market[96]. - The development of a high-solid content calcium stearate lubricant is underway, which is anticipated to yield two new products and improve market competitiveness[96]. - The company has initiated projects to produce high-performance PVC wallboard materials and organic auxiliary heat stabilizers, aligning with sustainable development strategies[96]. Risk Management - The company faces risks related to the inability to fully pass on raw material price increases to downstream customers[12]. - The company’s operating performance is subject to significant fluctuations due to raw material price volatility[12]. - The company has identified a new risk regarding the absorption of additional production capacity from fundraising projects[13]. - The company faces risks from raw material price fluctuations, particularly for stearic acid, which is influenced by palm oil prices[117]. - The company has established a strategic cooperation model with stable suppliers to mitigate the impact of raw material price volatility[118]. Corporate Governance and Compliance - The company has committed to fulfilling its corporate social responsibility by adhering to laws, protecting the environment, and providing employment opportunities[110]. - The company has no significant impact on its financial status or operating results from the recent accounting policy changes[105][106]. - The company has completed the deregistration of Dongguan Han Innovation Materials Technology Co., Ltd. as of October 21, 2022[109]. - The company emphasizes the importance of risk management and aims to enhance its resilience through the implementation of investment projects[113]. - The company has not reported any unprofitable situations or cumulative losses during the reporting period[111]. Stock and Shareholder Management - The company's stock was listed on the Beijing Stock Exchange on December 14, 2022[5]. - The company is currently fulfilling commitments related to stabilizing stock prices after its listing, which includes measures to address stock price dips below net asset value[135]. - The company has committed to strict adherence to profit distribution regulations as per its articles of association and relevant laws[134]. - The company will enhance the management of raised funds to ensure their safe and effective use, thereby protecting the interests of investors, especially small and medium-sized investors[154]. - The company will accept social supervision and implement strict measures to ensure the fulfillment of commitments, including timely public explanations for any failures[160]. Financial Strategy and Investment - The company plans to use up to CNY 87 million of idle raised funds for cash management to enhance efficiency[25]. - The company will increase investment in product research and development to accelerate the conversion of R&D results and enhance sales scale and profitability[156]. - A cost management strategy will be implemented to control expenses and improve profit margins, with specific optimization tasks assigned to various departments[156]. - The company commits to fulfilling measures to compensate for any dilution of immediate returns, and if not fulfilled, will publicly explain the reasons and apologize to shareholders[159].

证券代码：836957 证券简称：汉维科技 公告编号：2023-026 2022年度独立董事述职报告 作为东莞市汉维科技股份有限公司（以下简称"公司"）独立董事，2022年，独 立董事严格按照《证券法》《公司法》《上市公司独立董事规则》以及《公司章程》 等相关规定，诚实、勤勉、独立地履行职责，及时了解公司发展状况，积极出席相 关会议，参与重大经营决策并对重大事项独立、客观地发表意见，坚持职业操守， 谨慎行使法律及《公司章程》所赋予的权利，充分发挥独立董事的监督作用，切实 维护公司整体利益和全体股东的合法权益。现将2022年度工作情况报告如下： 一、董事会、股东大会出席情况 | 1、公司2022年度共计召开10次董事会，独立董事出席董事会情况如下： | | --- | | 独立董事 | 应出席股东大会次数 | 出席次数 | 委托出席次数 | 缺席次数 | | --- | --- | --- | --- | --- | | 黎江虹 | 6 | 6 | 0 | 0 | | 陈朝阳 | 6 | 6 | 0 | 0 | | 刘昱熙 | 6 | 6 | 0 | 0 | 二、发表独立董事意见情况 独立董事根据相关法律、法规 ...

东莞证券股份有限公司 关于东莞市汉维科技股份有限公司 公司治理专项核查报告 北京证券交易所： 东莞市汉维科技股份有限公司（以下简称"汉维科技"或"公司"）于 2022 年 12 月 14 日在北京证券交易所上市。东莞证券股份有限公司（以下简称"东莞 证券"或"保荐机构"）作为汉维科技本次向不特定合格投资者公开发行股票并 在北京证券交易所上市的保荐机构，根据《中华人民共和国公司法》（以下简称 "《公司法》"）、《中华人民共和国证券法》（以下简称"《证券法》"）和 《北京证券交易所股票上市规则（试行）》（以下简称"《上市规则》"）等相 关法律、法规等的规定对 2022 年度公司治理开展专项核查工作，现将核查情况 报告如下： 一、公司基本情况 公司为成立于 2008 年 7 月的民营企业。公司主要从事高分子材料环保助剂 的研发、生产和销售，公司主营产品为脂肪酸盐助剂和复合助剂。根据国家统计 局颁布的《国民经济行业分类》（GB/T 4754-2017），公司所属行业为"C26 化 学原料和化学制品制造业"大类下的"C2661 化学试剂和助剂制造"。公司控股 股东为周述辉，实际控制人为周述辉、谭志佳、荀育军、李拥军。截 ...